Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
Sponsor: Hellenic Cooperative Oncology Group
Summary
To determine somatic and germline pathogenic variants in patients with denovo metastatic breast cancer in order to map the molecular/genetic characteristics of DN- MBC aiming in comprehending the biology and highlighting potential novel treatment options for the disease.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
101
Start Date
1998-07-05
Completion Date
2026-04-15
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Interventions
NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
In patients with denovo metastatic breast cancer blood and tissue sample will be collected and then further analysed using NGS in order to detect somatic and germline pathogenic variants
Locations (1)
Evangelia Moirogiorgou
Athens, Greece